Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment
Why the study?
Anticoagulant treatment in cancer settings is broadly debated, and selecting patients with a balanced risk-benefit profile for anticoagulation remains complex.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May justify limited occult-cancer workup after unprovoked VTE; leaves open net benefit of extensive screening.
Structured PICO
P
Population
Patients with cancer-related venous thromboembolism
I
Intervention
Direct oral anticoagulants
C
Comparator
Conventional treatment
This review highlights the efficacy and safety of direct oral anticoagulants for the management and prophylaxis of cancer-related venous thromboembolism.
Cite This Study
Canonico et al. (2022) studied this question.